Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Laureline Brunner"'
Autor:
Claudio Schneider, Nicolas Rodondi, Carole Elodie Aubert, Laureline Brunner, Andreas Marti, Samuel Zbinden
Publikováno v:
BMJ Open, Vol 14, Iss 10 (2024)
Objectives In the context of limited evidence on statin use in primary cardiovascular prevention in older adults, we assessed physician perspectives on decision-making about statin continuation or discontinuation in this population.Design Qualitative
Externí odkaz:
https://doaj.org/article/1ca47d0ec2534ef682ffa5f3e93b631a
Autor:
Julia Bianca Bardoczi MMed, Laureline Brunner MD, Anne Spinewine PhD, Nicolas Rodondi MD, MAS, Carole Elodie Aubert MD, MSc
Publikováno v:
Gerontology and Geriatric Medicine, Vol 10 (2024)
Background: There is little evidence for statins for primary cardiovascular prevention in older adults. Consequently, it is important to assess patient attitudes toward the use of statins, which might differ from attitudes toward other medications. W
Externí odkaz:
https://doaj.org/article/06dded43207245a9950a81805cd5793e
Publikováno v:
BMJ Open, Vol 12, Iss 12 (2022)
Objective To synthesise the current knowledge on barriers and facilitators to deprescribing cardiovascular medications (CVMs) at the levels of patients, informal caregivers and healthcare providers (HCPs).Design/setting We conducted a systematic revi
Externí odkaz:
https://doaj.org/article/4ccd3584bae1494d9b816c2a7a286f68
Autor:
Catherine Hudon, Patrick Bodenmann, Nicolas Senn, Mary Malebranche, Olivier Hugli, Laureline Brunner, Marina Canepa Allen, Francis Vu, Christina Akré
Publikováno v:
BMJ Open, Vol 11, Iss 6 (2021)
Objectives Many interventions have been developed over the years to offer frequent users of the emergency department (FUEDs) better access to quality coordinated healthcare. Despite recognising the role primary care physicians (PCPs) play in FUEDs’
Externí odkaz:
https://doaj.org/article/209ed95c9453425e9da59ee420c3f64f
Publikováno v:
BMJ open. 12(12)
To synthesise the current knowledge on barriers and facilitators to deprescribing cardiovascular medications (CVMs) at the levels of patients, informal caregivers and healthcare providers (HCPs).We conducted a systematic review of studies exploring/a